XML 30 R30.htm IDEA: XBRL DOCUMENT v3.20.1
Restructuring (Tables)
12 Months Ended
Dec. 31, 2019
Restructuring Plan, July 2018 [Member]  
Summary of Total Amount Expected to Be Incurred and Liability
The following table shows the total amount expected to be incurred and the liability related to the July 2018 restructuring as at December 31, 2019:
 
(in thousands)
  
CLINICAL
TRIAL
CLOSING
COSTS
  
ONE-TIME

EMPLOYEE
TERMINATION
BENEFITS
  
CONTRACT
TERMINATION
COSTS
  
SAN
BRUNO
OFFICE
CLOSING
COSTS
  
TOTAL
EXPENSES
 
Amounts accrued as at January 1, 2018
  $—    $—    $—    $—    $—   
Charges
July 2018
   5,703   1,879   1,108   465   9,155 
Revised estimates during 2018
   41   2   187   5   235 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Total restructuring costs expected to be incurred
   5,744   1,881   1,295   470   9,390 
Amounts paid during 2018
   (2,204  (1,881  (1,201  (470  (5,756
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Amounts accrued at December 31, 2018
   3,540   —     94   —     3,634 
Revised estimates during 2019
   (1,957     12      (1,945
Amounts paid during 2019
   (1,583     (106     (1,689
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Amounts accrued at December 31, 2019
  $  $  $  $  $ 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Restructuring Plan, November 2018 [Member]  
Summary of Total Amount Expected to Be Incurred and Liability
The following table shows the total amount expected to be incurred and the liability related to the November 2018 restructuring as at December 31, 2019:
 
(in thousands)
  
ONE-TIME

EMPLOYEE
TERMINATION
BENEFITS
 
Total restructuring costs expected to be incurred
  $984 
Amount paid in 2018
   (922
  
 
 
 
Amount accrued at December 31, 2018
   62 
Restructuring costs incurred during 2019
   655 
Amount paid during the period ended December 31, 2019
   (702
Amount accrued at December 31, 2019
 
$
15
 
 
 
 
 
 
 
 
 
 
 
Restructuring charges expected to be incurred
 
 
1,645
 
Cumulative restructuring costs incurred as at December 31, 2019
   (1,639
  
 
 
 
Restructuring charges expected to be incurred in future periods
  $6